Back to Publications
August, 2021
MORNINGSKY Trial
BlueClinical is involved, through its Clinical Research Partnership Network, on the Phase 3 MORNINGSKY trial
BlueClinical is involved, through its Clinical Research Partnership Network, on the Phase 3 MORNINGSKY trial, a global multicenter study evaluating AT-527 in mild or moderate COVID-19 patients in an outpatient setting.
Learn more at https://www.covid19morningsky.com/PT
Other Publication
